Nicholas Boria is a Molecular Technologist 1 at Caris Life Sciences, where expertise includes Next-Generation Sequencing (NGS) and Whole Exome DNA sequencing for cancer analysis. Previous experience includes roles as a Research Technician 1 and Research Neuroscientist at the Ivy Brain Tumor Center, contributing to pioneering Phase 0 clinical trials and developing lentiviral vectors for glioblastoma research. Additional roles encompass sales positions at ACE Hardware and Batteries Plus Bulbs, along with technology management at CREST. Nicholas holds a degree in Neuroscience and Cognitive Science from the University of Arizona and possesses foundational education in biotechnology and biology through various institutions.